肺癌已成为我国第一大癌症,血管内皮细胞生长因子(VEGF)能特异性促使内皮细胞增殖及直接参与血管增生,与肺癌肿瘤的生长、浸润和转移有密切关系。而中医药针对肺癌VEGF的治疗研究呈现出可喜苗头,展示了近年运用中医理论,切中病机,确立治则,有效抑制肺癌VEGF高表达的研究成果,并提出今后中医治疗策略。 Lung cancer has become the largest cancer in China. Vascular endothelial growth factor (VEGF) can specifically promote endothelial cell proliferation and directly participate in vascular proliferation, which is closely related to the growth, invasion and metastasis of lung cancer. Chinese medicine for the treatment of lung cancer showed gratifying vaccine research, demonstrated the use of traditional Chinese medicine theory in recent years, cut the pathogenesis, established rule, effectively inhibit the high expression of VEGF in lung cancer research results and put forward the strategy of TCM treatment.